{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T13:13:50Z","timestamp":1777554830301,"version":"3.51.4"},"reference-count":37,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Dermatitis\u00ae"],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:p>\n                    <jats:underline>\n                      <jats:bold>\n                        <jats:italic toggle=\"yes\">Abstract: Background:<\/jats:italic>\n                      <\/jats:bold>\n                    <\/jats:underline>\n                    Patch testing is gold standard for identifying the source of allergic contact dermatitis (ACD).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:underline>\n                      <jats:bold>\n                        <jats:italic toggle=\"yes\">Objective:<\/jats:italic>\n                      <\/jats:bold>\n                    <\/jats:underline>\n                    To report patch testing results from the Massachusetts General Hospital (MGH) Occupational and Contact Dermatitis Clinic from 2017 to 2022.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:underline>\n                      <jats:bold>\n                        <jats:italic toggle=\"yes\">Methods:<\/jats:italic>\n                      <\/jats:bold>\n                    <\/jats:underline>\n                    Retrospective analysis of patients referred to MGH for patch testing, 2017\u20132022.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:underline>\n                      <jats:bold>\n                        <jats:italic toggle=\"yes\">Results:<\/jats:italic>\n                      <\/jats:bold>\n                    <\/jats:underline>\n                    In total, 1438 patients were included. At least 1 positive patch test (PPT) reaction was observed in 1168 (81.2%) patients and at least 1 relevant PPT reaction was observed in 1087 (75.6%) patients. The most common allergen with a PPT was nickel (21.5%), followed by hydroperoxides of linalool (20.4%) and balsam of Peru (11.5%). Sensitization rates statistically increased over time for propylene glycol and decreased for 12 other allergens (all\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    values &lt;0.0004).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:underline>\n                      <jats:bold>\n                        <jats:italic toggle=\"yes\">Limitations:<\/jats:italic>\n                      <\/jats:bold>\n                    <\/jats:underline>\n                    Retrospective design, single institution tertiary referral population, and variations in allergens and suppliers across the study period.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:underline>\n                      <jats:bold>\n                        <jats:italic toggle=\"yes\">Conclusion:<\/jats:italic>\n                      <\/jats:bold>\n                    <\/jats:underline>\n                    The field of ACD is constantly evolving. Regular analysis of patch test data is crucial to identify emerging and diminishing contact allergen trends.\n                  <\/jats:p>","DOI":"10.1089\/derm.2023.0085","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T11:08:36Z","timestamp":1684926516000},"page":"525-531","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Patch Testing Results from the Massachusetts General Hospital Occupational and Contact Dermatitis Clinic, 2017\u20132022"],"prefix":"10.1177","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0101-2017","authenticated-orcid":false,"given":"Hadley","family":"Johnson","sequence":"first","affiliation":[{"name":"From the,  University of Minnesota Medical School, Minneapolis, Minnesota, USA."},{"name":"Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JiaDe","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13119"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/JW9.0000000000000006"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15875"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000417"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000729"},{"key":"e_1_3_2_7_2","unstructured":"Amended Safety Assessment of Methylisothiazolinone and Methylchloroisothiazolinone as Used in Cosmetics Amended Report for Public Comment. Updated September 30 2019. Available from: https:\/\/www.cir-safety.org\/sites\/default\/files\/mcimi092019TAR.pdf [Last accessed: September26 2020]."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajcd.1998.2919"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2009.08084"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000593"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-662-10302-9_21"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000385"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2011.01964.x"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.4314"},{"key":"e_1_3_2_15_2","volume-title":"StatPearls","author":"Rishor-Olney CR","year":"2023","unstructured":"Rishor-Olney CR, , Gnugnoli DM. Nickel Allergy. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2023."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0b013e31828afab2"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27186120"},{"key":"e_1_3_2_18_2","volume-title":"StatPearls","author":"Matin T","year":"2023","unstructured":"Matin T, , Goodman MB. Benzoyl peroxide. In: StatPearls. [Internet]. Treasure Island, FL: StatPearls Publishing; 2023."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/der.0000000000000101"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/cod.13137"},{"issue":"1","key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cod.14064","article-title":"Limonene and linalool hydroperoxides review: pros and cons for routine patch testing","volume":"87","author":"Ogueta IA","year":"2022","unstructured":"Ogueta IA, , Brared Christensson J, , Gim\u00e9nez-Arnau E, et al. Limonene and linalool hydroperoxides review: pros and cons for routine patch testing. Contact Dermatitis. 2022; 87(1):1\u201312. doi: 10.1111\/cod.14064.","journal-title":"Contact Dermatitis"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2019.03.028"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/cod.14008"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2023.105341"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2008.08039"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13671-022-00353-w"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000307"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200304110-00006"},{"issue":"1","key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2133.2009.09157.x","article-title":"The prevalence and morbidity of sensitization to fragrance mix I in the general population","volume":"161","author":"Thyssen JP","year":"2009","unstructured":"Thyssen JP, , Linneberg A, , Menn\u00e9 T, et al. The prevalence and morbidity of sensitization to fragrance mix I in the general population. Br J Dermatol. 2009; 161(1):95\u2013101. doi: 10.1111\/j.1365-2133.2009.09157.x.","journal-title":"Br J Dermatol"},{"issue":"4","key":"e_1_3_2_30_2","first-page":"192","article-title":"Parabens: the 2019 nonallergen of the year","volume":"103","author":"Reeder M","year":"2019","unstructured":"Reeder M, , Atwater AR. Parabens: the 2019 nonallergen of the year. Cutis. 2019; 103(4):192\u2013193.","journal-title":"Cutis"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.07.059"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1089\/derm.2022.29017.jdk"},{"issue":"5","key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/cod.14181","article-title":"Preservatives in non-cosmetic products: increasing human exposure requires action for protection of health","volume":"87","author":"Lid\u00e9n C","year":"2022","unstructured":"Lid\u00e9n C, , Andersson N, , White IR. Preservatives in non-cosmetic products: increasing human exposure requires action for protection of health. Contact Dermatitis. 2022; 87(5):389\u2013405. doi: 10.1111\/cod.14181.","journal-title":"Contact Dermatitis"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.03.042"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000342"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.2310\/6620.2010.09077"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.12.022"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27154862"}],"container-title":["Dermatitis\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/derm.2023.0085","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/derm.2023.0085","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/derm.2023.0085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:07:06Z","timestamp":1777399626000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/derm.2023.0085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12,1]]}},"alternative-id":["10.1089\/derm.2023.0085"],"URL":"https:\/\/doi.org\/10.1089\/derm.2023.0085","relation":{},"ISSN":["1710-3568","2162-5220"],"issn-type":[{"value":"1710-3568","type":"print"},{"value":"2162-5220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,16]]}}}